All Stories

  1. Lesbian, Gay, and Transgender Veterans’ Experiences in the Veterans Health Administration: Positive Signs and Room for Improvement.
  2. Health Differences Among Lesbian, Gay, and Transgender Veterans by Rural/Small Town and Suburban/Urban Setting
  3. Unmet informational and supportive care needs of patients following cystectomy for bladder cancer based on age, sex, and treatment choices
  4. Threat of Sexual Disqualification: The Consequences of Erectile Dysfunction and Other Sexual Changes for Gay and Bisexual Men With Prostate Cancer
  5. Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men With Heterosexual Men
  6. The Need for Survivorship Care in Genitourinary Cancers: Considerations from SUO and LUGPA
  7. The effects of attachment and outness on illness adjustment among gay men with prostate cancer
  8. An Exploration of Returning Veterans' Sexual Health Issues Using a Brief Self‐Report Measure
  9. Editorial Comment on “The Impact of Prostate Cancer Treatment on the Sexual Quality of Life for Men-Who-Have-Sex-with-Men”
  10. Perspectives on Sexual Health and Function of Recent Male Combat Veterans of Iraq and Afghanistan
  11. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance
  12. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward
  13. Gay Men and Prostate Cancer: Opportunities to Improve HRQOL and Access to Care
  14. Preparing Trainees to Deliver Patient-Centered Care in an Ambulatory Cancer Clinic
  15. Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer: Challenges for Sexual Health Providers
  16. Sexual dysfunction in bladder cancer
  17. Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer
  18. Educational Opportunities in Bladder Cancer: Increasing Cystoscopic Adherence and the Availability of Smoking-Cessation Programs
  19. Cisplatin-Ineligible and Chemotherapy-Ineligible Patients Should Be the Focus of New Drug Development in Patients With Advanced Bladder Cancer
  20. A Review of Sexual Health Among Lesbian, Gay, and Bisexual Veterans
  21. Summary of the 6th annual bladder cancer think tank: New directions in urologic research
  22. Racial Differences in Sexual Dysfunction Among Postdeployed Iraq and Afghanistan Veterans
  23. Symptom Management Strategies for Men with Early-Stage Prostate Cancer: Results from the Prostate Cancer Patient Education Program (PC PEP )
  24. Assessment and Documentation of Sexual Health Issues of Recent Combat Veterans Seeking VHA Care
  25. Utility of a Partner Communication Scale and a Personal Meaning Scale in Newly Diagnosed HIV-Infected Persons
  26. Psychosocial aspects of active surveillance
  27. Sexual Dysfunction among Male Veterans Returning from Iraq and Afghanistan: Prevalence and Correlates
  28. A Pilot Study of HIV/STI Risk among Men Having Sex with Men Using Erectile Dysfunction Medications: Challenges and Opportunities for Sexual Medicine Physicians
  29. Factor Structure and Convergent Validity of the Inventory of Interpersonal Problems in an Inpatient Setting
  30. Cancer perceptions: implications from the 2007 Health Information National Trends Survey
  31. Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship
  32. Patient Resources Available to Bladder Cancer Patients: A Pilot Study of Healthcare Providers
  33. Psychosocial Aspects of AS
  34. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance
  35. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer
  36. Development and validation of a novel idiographic measure of cystectomy patients’ goals and concerns before surgery
  37. 163 GAY MEN WITH PROSTATE CANCER REPORT SIGNIFICANTLY WORSE HRQOL THAN HETEROSEXUAL MEN
  38. 661 RACIAL/ETHNIC DIFFERENCES IN UPPER-TRACT UROTHELIAL CANCER
  39. Longitudinal Differences in Psychological Outcomes for Men with Erectile Dysfunction: Results from ExCEEDTM
  40. ORIGINAL RESEARCH—ERECTILE DYSFUNCTION: Clinical and Psychosocial Characteristics of Men with Erectile Dysfunction: Baseline Data from ExCEED™
  41. REPORTS: The Bolger Conference on PDE‐5 Inhibition and HIV Risk: Implications for Health Policy and Prevention
  42. Changes in specific domains of sexual function and sexual bother after radical prostatectomy
  43. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life
  44. Bladder Cancer Detection, Treatment and Outcomes: Opportunities and Challenges
  45. Integrating outcomes assessment and research into clinical care in inpatient adult psychiatric treatment
  46. Psychosocial characteristics of psychiatric inpatients at admissions and discharge: The Menninger Clinic Adult Outcomes Project
  47. Sexual Rehabilitation After Localized Prostate Cancer
  48. Sexual Side Effects and Prostate Cancer Treatment Decisions
  49. Fear of Recurrence, Symptom Burden, and Health-Related Quality of Life in Men With Prostate Cancer
  50. Urinary diversion: evidence-based outcomes assessment and integration into patient decision-making
  51. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor
  52. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database
  53. The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on Surveillance
  54. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer
  55. Education predicts quality of life among men with prostate cancer cared for in the department of Veterans affairs
  56. Cumulative cost pattern comparison of prostate cancer treatments
  57. Quality of Life for Men Receiving a Second Treatment for Prostate Cancer
  58. Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE
  59. Changing Patterns of Pelvic Lymphadenectomy for Prostate Cancer: Results From CaPSURE™
  60. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: Data from CaPSURE
  61. Androgen-deprivation therapy as primary treatment for localized prostate cancer
  62. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer
  63. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer
  64. History of Diabetes, Clinical Features of Prostate Cancer, and Prostate Cancer Recurrence-Data from CaPSURETM (United States)
  65. THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CANCER OF THE PROSTATE RISK ASSESSMENT SCORE: A STRAIGHTFORWARD AND RELIABLE PREOPERATIVE PREDICTOR OF DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY
  66. TREATMENT OF PATIENTS WITH HIGH RISK LOCALIZED PROSTATE CANCER: RESULTS FROM CANCER OF THE PROSTATE STRATEGIC UROLOGICAL RESEARCH ENDEAVOR (CaPSURE)
  67. THE IMPACT OF OBESITY ON HEALTH RELATED QUALITY OF LIFE BEFORE AND AFTER RADICAL PROSTATECTOMY (DATA FROM CaPSURE)
  68. Is Quality if Life Different for Men with Erectile Dysfunction and Prostate Cancer Compared to Men with Erectile Dysfunction Due to Other Causes? Results from the ExCEED Data Base
  69. Longitudinal Differences in Disease Specific Quality of Life in Men With Erectile Dysfunction: Results From the Exploratory Comprehensive Evaluation of Erectile Dysfunction Study
  70. Do Impotent Men With Diabetes Have More Severe Erectile Dysfunction and Worse Quality of Life Than the General Population of Impotent Patients?: Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database
  71. Psychological Impact of Erectile Dysfunction: Validation of a New Health Related Quality of Life Measure for Patients With Erectile Dysfunction
  72. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE
  73. Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy
  74. A controlled smoking cessation trial for substance-dependent inpatients.
  75. A controlled smoking cessation trial for substance-dependent inpatients.